newest glp 1 medication Diabetes advocacy group discourages use of compounded GLP-1 drugs Professor Receives Grant to Study

The tablets are designed to support overall health

Employers are facing difficult decisions about how to address the costs and health challenges associated with this trend. The study will follow two groups: Individuals with obesity or overweight who are using obesity management medications A matched comparison group of individuals with obesity or overweight and similar characteristics who are not using obesity management medications The study will run through November 2029

Randall VA, Jenner TJ, Hibberts NA, De Oliveira IO, Vafaee T

Understanding these patterns helps patients push through the difficult early period of either medication without abandoning treatment prematurely

Martindale, X